Benchmark (BMK) FY20 results analyst presentation

Trond Williksen, CEO & Spetima Maguire, CFO present FY20 results to analysts. A transformational year, completing the restructuring, with good growth opportunities and long-term growth drivers.

Trond Williksen, CFO
Introduction – 00:20
Overview – 00:49
Benchmarks objectives – 04:21

Septima Maguire, CFO
Financials – 05:49

Trond Williksen, CFO
Strategy – 18:23
Outlook & guidance – 28:08

Benchmark Holdings plc is engaged in the provision of aquaculture health, genetics and nutrition. The Company’s segments include genetics, advanced nutrition and health. The Company develops products that helps fish and shrimp to improve their sustainability and profitability by improving yield, quality, and by reducing mortality. The Company’s products include high genetic quality ova for salmon, shrimp and tilapia, and breeding, program, specialist feeds for early stage shrimp and fish; probiotics, biocides and medicines.

You might be interested in